Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Dementia Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 MAO Inhibitors
  • 1.3.3 Cholinesterase Inhibitors
  • 1.3.4 Glutamate Inhibitors
• 1.4 Market Segment by Application
  • 1.4.1 Global Dementia Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacies
  • 1.4.3 Retail Pharmacies
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Dementia Drugs Market Size
  • 2.1.1 Global Dementia Drugs Revenue 2014-2025
  • 2.1.2 Global Dementia Drugs Sales 2014-2025
• 2.2 Dementia Drugs Growth Rate by Regions
  • 2.2.1 Global Dementia Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Dementia Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Dementia Drugs Sales by Manufacturers
  • 3.1.1 Dementia Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Dementia Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Dementia Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Dementia Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Dementia Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Dementia Drugs Price by Manufacturers
• 3.4 Key Manufacturers Dementia Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Dementia Drugs Market
• 3.6 Key Manufacturers Dementia Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 MAO Inhibitors Sales and Revenue (2014-2019)
  • 4.1.2 Cholinesterase Inhibitors Sales and Revenue (2014-2019)
  • 4.1.3 Glutamate Inhibitors Sales and Revenue (2014-2019)
• 4.2 Global Dementia Drugs Sales Market Share by Type
• 4.3 Global Dementia Drugs Revenue Market Share by Type
• 4.4 Dementia Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Dementia Drugs Sales by Application

6 United States

• 6.1 United States Dementia Drugs Breakdown Data by Company
• 6.2 United States Dementia Drugs Breakdown Data by Type
• 6.3 United States Dementia Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Dementia Drugs Breakdown Data by Company
• 7.2 European Union Dementia Drugs Breakdown Data by Type
• 7.3 European Union Dementia Drugs Breakdown Data by Application

8 China

• 8.1 China Dementia Drugs Breakdown Data by Company
• 8.2 China Dementia Drugs Breakdown Data by Type
• 8.3 China Dementia Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Dementia Drugs Breakdown Data by Company
• 9.2 Rest of World Dementia Drugs Breakdown Data by Type
• 9.3 Rest of World Dementia Drugs Breakdown Data by Application
• 9.4 Rest of World Dementia Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Dementia Drugs Sales by Countries
  • 9.4.2 Rest of World Dementia Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Eisai, Inc
  • 10.1.1 Eisai, Inc Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.1.4 Dementia Drugs Product Introduction
  • 10.1.5 Eisai, Inc Recent Development
• 10.2 Janssen Pharmaceuticals, Inc
  • 10.2.1 Janssen Pharmaceuticals, Inc Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.2.4 Dementia Drugs Product Introduction
  • 10.2.5 Janssen Pharmaceuticals, Inc Recent Development
• 10.3 Biogen Pharmaceuticals
  • 10.3.1 Biogen Pharmaceuticals Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.3.4 Dementia Drugs Product Introduction
  • 10.3.5 Biogen Pharmaceuticals Recent Development
• 10.4 Forest Laboratories, Inc
  • 10.4.1 Forest Laboratories, Inc Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.4.4 Dementia Drugs Product Introduction
  • 10.4.5 Forest Laboratories, Inc Recent Development
• 10.5 Eli Lilly and Company
  • 10.5.1 Eli Lilly and Company Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.5.4 Dementia Drugs Product Introduction
  • 10.5.5 Eli Lilly and Company Recent Development
• 10.6 Novartis AG
  • 10.6.1 Novartis AG Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.6.4 Dementia Drugs Product Introduction
  • 10.6.5 Novartis AG Recent Development
• 10.7 Sanofi S.A
  • 10.7.1 Sanofi S.A Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.7.4 Dementia Drugs Product Introduction
  • 10.7.5 Sanofi S.A Recent Development
• 10.8 AstraZeneca GmbH
  • 10.8.1 AstraZeneca GmbH Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.8.4 Dementia Drugs Product Introduction
  • 10.8.5 AstraZeneca GmbH Recent Development
• 10.9 F. Hoffmann-La Roche
  • 10.9.1 F. Hoffmann-La Roche Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.9.4 Dementia Drugs Product Introduction
  • 10.9.5 F. Hoffmann-La Roche Recent Development
• 10.10 Merck & Co., Inc
  • 10.10.1 Merck & Co., Inc Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Dementia Drugs
  • 10.10.4 Dementia Drugs Product Introduction
  • 10.10.5 Merck & Co., Inc Recent Development
• 10.11 Valeant Pharmaceutical International
• 10.12 Pfizer Inc
• 10.13 Teva Pharmaceuticals Industries

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Dementia Drugs Sales Channels
  • 11.2.2 Dementia Drugs Distributors
• 11.3 Dementia Drugs Customers

12 Market Forecast

• 12.1 Global Dementia Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Dementia Drugs Sales Forecast by Type
• 12.3 Global Dementia Drugs Sales Forecast by Application
• 12.4 Dementia Drugs Forecast by Regions
  • 12.4.1 Global Dementia Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Dementia Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Dementia Drugs is 13900 million US$ and it will reach 26500 million US$ in 2025, growing at a CAGR of 8.4% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dementia Drugs.

This report studies the global market size of Dementia Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dementia Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries

Market Segment by Product Type
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors

Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Dementia Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dementia Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Dementia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025